Hans Konrad
Hans Konrad Mueller-Hermelink, Wurzburg DE
Patent application number | Description | Published |
---|---|---|
20090202570 | PM-2 ANTIBODIES, FUNCTIONAL FRAGMENTS AND METHODS FOR TREATING METASTASIS - The invention provides PM-2 antibodies, functional fragments, modified and variant forms, nucleic acid and other compositions. Antibodies, functional fragments, modified and variant forms, nucleic acid and other compositions are useful in treatment and diagnostic methods. One method includes treating metastasis of a neoplasia, tumor or cancer in a subject in need of treatment by administering to the subject an amount of a PM-2 antibody or functional fragment thereof effective to treat metastasis of the neoplasia, tumor or cancer in the subject. | 08-13-2009 |
20100317826 | NEOPLASM SPECIFIC ANTIBODIES AND USES THEREOF - The present invention features polypeptides, such as antibodies, and their use in the treatment and diagnosis of neoplasms. | 12-16-2010 |
20110076763 | NEOPLASM SPECIFIC ANTIBODIES AND USES THEREOF - The present invention features polypeptides, such as antibodies, and their use in the treatment and diagnosis of neoplasms. | 03-31-2011 |
20110287021 | NEOPLASM SPECIFIC ANTIBODIES AND USES THEREOF - The present invention features polypeptides, such as antibodies, and their use in the treatment and diagnosis of neoplasms. | 11-24-2011 |
Hans Konrad Mueller-Hermelink, Wuerzburg DE
Patent application number | Description | Published |
---|---|---|
20110027182 | SUBSTANCE FOR OBTAINING HIGHLY EFFECTIVE TUMOR MEDICATIONS AS WELL AS A PROCESS - The invention relates to a substance and a process for obtaining anti-tumor agents. | 02-03-2011 |
Hans Konrad MÜller-Hermelink, Wurzburg DE
Patent application number | Description | Published |
---|---|---|
20090136420 | Neoplasm-specific polypeptides and their uses - The present invention features novel polypeptides and methods of using these polypeptides in the diagnosis, detection, monitoring, and treatment of neoplasms in a mammal, e.g., a human. | 05-28-2009 |
20100316630 | ANTI-IDIOTYPE ANTIBODIES OF THE HUMAN MONOCLONAL ANTIBODY SC-1, AND THEIR PRODUCTION AND USE - The invention features anti-idiotype antibodies of the human monoclonal antibody SC-1, as well as methods for producing and using the anti-idiotype antibodies. | 12-16-2010 |
20130039849 | ADENOCARCINOMA SPECIFIC ANTIBODY SAM-6, AND USES THEREOF - The present invention features a polypeptide, such as an antibody produced by the hybridoma SAM-6 and its use in the treatment and diagnosis of neoplasms. | 02-14-2013 |
Hans Konrad MÜller-Hermelink, Wurzburg DE
Patent application number | Description | Published |
---|---|---|
20100316630 | ANTI-IDIOTYPE ANTIBODIES OF THE HUMAN MONOCLONAL ANTIBODY SC-1, AND THEIR PRODUCTION AND USE - The invention features anti-idiotype antibodies of the human monoclonal antibody SC-1, as well as methods for producing and using the anti-idiotype antibodies. | 12-16-2010 |
20130039849 | ADENOCARCINOMA SPECIFIC ANTIBODY SAM-6, AND USES THEREOF - The present invention features a polypeptide, such as an antibody produced by the hybridoma SAM-6 and its use in the treatment and diagnosis of neoplasms. | 02-14-2013 |